{"cdcTestId":"2013-0761","testcaseName":"Dose 2 to dose 3 Rotateq interval 28 days","vaccineGroup":"ROTA","evaluationTestType":"Interval: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-06-20T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ROTATEQ","cvx":"116","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2017-12-07T10:56:01.227","generalDescription":"This test case describes when dose #3 of a RotaTeq vaccine is administered at, at least 14 weeks of age and at least 4 weeks (28 days) from dose #2, that the dose is considered to be valid. The series is complete.","changedInVersion":"1.0","reasonForChange":""}